Protein– tag –
-
First Half 2026 Sees 24 New Small-Molecule Approvals: Pioneering PROTAC Vepdegestrant and Oral GLP-1 Orforglipron Enter Market
Chemexpress China Overview Twenty-four small-molecule drugs received their first global approval in the first half of 2026, with 95.8% being oral dosage forms. Key highlights include the approval of the first commercial PROTAC, vepdegest... -
Biopharmaceuticals Contract Manufacturing Market Expands Amid Global Demand: CDMOs Scale Up Capacity
openPR.com Unknown Overview This article provides an overview of a market research report published by openPR.com. The biopharmaceutical contract manufacturing market is growing due to increased demand for biosimilars, expanded investmen... -
First PROTAC Approval Validates Targeted Protein Degradation as a Breakthrough Modality for Cancer Treatment
Converge Bio Unknown Overview The FDA approval of vepdegestrant, developed by Arvinas and Pfizer, signifies a major milestone for targeted protein degradation (TPD). This first-in-class PROTAC, approved for ER+/HER2-, ESR1-mutated advanc... -
FDA Approves First PROTAC Vepdegestrant (ARV-471) for ER+/HER2- Breast Cancer, Ushering in a New Era of Targeted Protein Degradation
Journal of Medicinal Chemistry - ACS Publications USA Overview On May 1, 2026, the FDA approved vepdegestrant (ARV-471; Veppanu), making it the first heterobifunctional PROTAC protein degrader approved for clinical practice. Indicated fo... -
AI Accelerates Next-Gen Drug Design: From De Novo Protein Creation to Optimized Clinical Trials
SiTech Blog (MIT Technology Review analysis) USA Overview Artificial intelligence is revolutionizing drug discovery by enhancing every stage from protein structure prediction to clinical trial optimization. Generative models like RFdiffu... -
Microfluidic Platform Enables Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes, ACS Analytical Chemistry Reports
Analytical Chemistry - ACS Publications USA Overview Research published in ACS Analytical Chemistry describes the development of a microfluidic chip for multiplexed detection of breast cancer-specific miRNA and protein biomarkers on exos... -
Forbes Highlights Convergence of Space Tech with AI, Quantum, and Nanotech; Microgravity Research Accelerates New Drug Discovery and Regenerative Medicine
Forbes USA Overview A Forbes article emphasizes the synergistic impact of exponential technologies—AI, quantum computing, and nanotechnology—with increasing reliance on space infrastructure. Microgravity research, in particular, shows gr... -
Scaling Animal-Free Proteins from Precision Fermentation Faces Challenges: Cost and Process Control Barriers from Lab to Market
MDPI Switzerland Overview Scaling animal-free proteins produced via precision fermentation from lab to industrial production faces significant challenges, including maintaining strain performance, high media costs, and precise bioprocess... -
Precision Fermentation Emerges as Transformative Food Production Technology, Enabling Scalable and Cost-Effective Alternative Ingredient Supply
KLBD Kosher Certification UK Overview Precision fermentation is rapidly gaining recognition as an innovative technology in food production, enabling the scalable and cost-effective manufacturing of diverse ingredients, including those ch... -
Beckman Coulter Showcases BioLector XT Micro Bioreactor and Biomek i5 Automated Liquid Handler to Accelerate Precision Fermentation and Alternative Protein Research
Beckman Coulter Life Sciences (YouTube) USA Overview Chris Saenz of Beckman Coulter Life Sciences introduced key technologies accelerating early-stage microbiology engineering for precision fermentation and alternative proteins. The BioL...
